Abstract
Cancer sera have higher levels of serum protein-bound fucose than sera from healthy individuals. In an attempt to identify the cause of this increase, fucoproteins were extracted from the sera of cancer patients and healthy individuals using a fucose-specific lectin (lotus tetragonolobus) coupled to Sepharose, and were analysed by polyacrylamide gel electrophoresis and silver staining. Of the several consistent changes observed for the cancer sera, the most striking was a large increase in a component of 40-45 Kdaltons. The expression of this component in the cancer sera was related to the elevation in serum fucose levels. Two dimensional (2D) electrophoretic analysis of lectin extracts showed that this component had a similar isoelectric point to the beta chains of haptoglobin. Its identity as haptoglobin was confirmed using Western blotting and an anti-haptoglobin antibody. Fucosylated haptoglobins (FHp) were also isolated from some rheumatoid arthritis sera, but there was no correlation between serum fucose levels and the FHp expression. The FHp in cancer sera was of higher molecular weight than that found in rheumatoid sera. Serial specimens from two ovarian cancer patients undergoing chemotherapy had elevated FHp associated with increased amounts of tumour. To the best of our knowledge this is the first time a molecule of this type has been reported in cancer sera and because of its uniqueness it deserves further investigation as a potential cancer marker.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thompson, S., Turner, G. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer 56, 605–610 (1987). https://doi.org/10.1038/bjc.1987.249
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.249
This article is cited by
-
Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis
Nature Communications (2022)
-
Glycans and glycoproteins as specific biomarkers for cancer
Analytical and Bioanalytical Chemistry (2017)
-
Glycosylation: a hallmark of cancer?
Glycoconjugate Journal (2017)
-
Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer
Indian Journal of Clinical Biochemistry (2004)
-
An improved ELISA for the determination of sialyl Lewisx structures on purified glycoconjugates
Glycoconjugate Journal (1996)